Israeli Co.'s Appeal Dies at the Supreme Court

Law360, New York (June 19, 2007, 12:00 AM EDT) -- The Supreme Court on Monday dealt a fatal blow to Israel Bio-Engineering Project's patent infringement case against Amgen Inc., letting stand an appellate court ruling that IBEP cannot sue because it cannot prove it is the patent's sole owner.

The justices denied IBEP's appeal, which was filed May 18, for a writ of certiorari. In February, the U.S. Court of Appeals for the Federal Circuit denied IBEP's appeal to rehear the case en banc after affirming a district court decision that found that Yeda Research and...
To view the full article, register now.